BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho WCS. Application of proteomics in non-small-cell lung cancer. Expert Review of Proteomics 2015;13:1-4. [DOI: 10.1586/14789450.2016.1121813] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Shi S, Wu T, Ma Z, Zhang X, Xu K, Tian Q, Gao L, Yin X, Xu S, Yang S. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5. J Cancer Res Clin Oncol 2022. [PMID: 36175801 DOI: 10.1007/s00432-022-04375-6] [Reference Citation Analysis]
2 Ma N, Si L, Yang M, Li M, He Z. A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation. Sci Rep 2021;11:5855. [PMID: 33712694 DOI: 10.1038/s41598-021-85246-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Abolfathi H, Sheikhpour M, Shahraeini SS, Khatami S, Nojoumi SA. Studies in lung cancer cytokine proteomics: a review. Expert Rev Proteomics 2021;18:49-64. [PMID: 33612047 DOI: 10.1080/14789450.2021.1892491] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Hu Y, Cheng Y, Jiang X, Zhang Y, Wang H, Ren H, Xu Y, Jiang J, Wang Q, Su H, Zhang B, Qiu X. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway. Exp Cell Res 2021;400:112496. [PMID: 33485844 DOI: 10.1016/j.yexcr.2021.112496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Goebel C, Louden CL, Mckenna R Jr, Onugha O, Wachtel A, Long T. Blood test shows high accuracy in detecting stage I non-small cell lung cancer. BMC Cancer 2020;20:137. [PMID: 32085733 DOI: 10.1186/s12885-020-6625-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Marrugal Á, Ferrer I, Pastor MD, Ojeda L, Quintanal-Villalonga Á, Carnero A, Molina-Pinelo S, Paz-Ares L. Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry. Cells 2019;8:E806. [PMID: 31370342 DOI: 10.3390/cells8080806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Pasini L, Ulivi P. Liquid Biopsy for the Detection of Resistance Mechanisms in NSCLC: Comparison of Different Blood Biomarkers. J Clin Med 2019;8:E998. [PMID: 31323990 DOI: 10.3390/jcm8070998] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
8 Böttger F, Schaaij-visser TB, de Reus I, Piersma SR, Pham TV, Nagel R, Brakenhoff RH, Thunnissen E, Smit EF, Jimenez CR. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction. Journal of Proteomics 2019;196:106-19. [DOI: 10.1016/j.jprot.2019.01.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
9 Cheung CHY, Juan HF. Quantitative proteomics in lung cancer. J Biomed Sci 2017;24:37. [PMID: 28615068 DOI: 10.1186/s12929-017-0343-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 10.4] [Reference Citation Analysis]
10 Ağababaoğlu İ, Önen A, Demir AB, Aktaş S, Altun Z, Ersöz H, Şanl A, Özdemir N, Akkoçlu A. Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma. Medicine (Baltimore) 2017;96:e5903. [PMID: 28178129 DOI: 10.1097/MD.0000000000005903] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
11 Rovithi M, Lind JSW, Pham TV, Voortman J, Knol JC, Verheul HMW, Smit EF, Jimenez CR. Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer. Prot Clin Appl 2016;10:743-9. [DOI: 10.1002/prca.201600025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]